Why the study?
Despite known endothelial dysfunction after COVID-19, little is known about COVID-19-related vasospastic angina.
This case highlights that vasospastic angina should be considered as a differential diagnosis in patients presenting with chest pain after recovering from COVID-19.
There is much research on cardiovascular complications associated with coronavirus disease 2019 (COVID-19). However, despite the endothelial dysfunction that can occur after the disease, little is known about COVID-19-related vasospastic angina (VSA). Here, we report the first case of a patient with VSA following COVID-19 in Korea. He reported tight chest pain and dyspnea; however, transthoracic echocardiography, chest computed tomography, and laboratory tests did not reveal abnormalities. He underwent 24-h Holter monitoring, and early-morning electrocardiography showed ST elevation for about 3 min followed by non-sustained ventricular tachycardia for about 5 s. After subsequent recovery of ST change, the patient complained chest pain. We diagnosed him with VSA and prescribed a calcium channel blocker and nitrates, after which his symptoms resolved.
No takes yet. Share an insight, caveat, or question.
Tae‐Sun Kim (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: